Retour
34
Fourchette du Jour
3,22 €
3,33 €
Fourchette 52 Semaines
2,98 €
7,18 €
Volume
11 126 219
Moyenne 50J / 200J
3,92 €
/
4,80 €
Clôture Précédente
3,25 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,2 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | -59,5 | 3,7 |
| Net Margin % | -863,4 | 3,9 |
| Rev Growth 5Y % | 65,3 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
11,00 €
+240.6%
BPA Prévisionnel
-0,95 €
CA Est.
85 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
-0,94 €
-2,00 € – -0,51 €
|
250 M | 4 |
| FY2028 |
-0,45 €
-0,95 € – -0,24 €
|
440 M | 3 |
| FY2027 |
-0,85 €
-0,99 € – -0,66 €
|
140 M | 6 |
Points Clés
Revenue grew 65,31% annually over 5 years — strong growth
Debt/Equity of 0,07 — conservative balance sheet
Negative free cash flow of -378,28M
PEG of 0,19 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 38,39%
Capital efficient — spends only 8,66% of revenue on capex
Croissance
Revenue Growth (5Y)
65,31%
Revenue (1Y)26,92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-59,54%
ROIC-40,21%
Net Margin-863,35%
Op. Margin-867,87%
Sécurité
Debt / Equity
0,07
Current Ratio5,50
Interest Coverage-358,08
Valorisation
P/E Ratio
-2,24
P/B Ratio1,28
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26,92% | Revenue Growth (3Y) | 30,46% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 65,31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 74,68M | Net Income (TTM) | -644,76M |
| ROE | -59,54% | ROA | -43,74% |
| Gross Margin | -61,96% | Operating Margin | -867,87% |
| Net Margin | -863,35% | Free Cash Flow (TTM) | -378,28M |
| ROIC | -40,21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 5,50 |
| Interest Coverage | -358,08 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,24 | P/B Ratio | 1,28 |
| P/S Ratio | 19,34 | PEG Ratio | 0,19 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,44B | Enterprise Value | 779,10M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 74,68M | 58,84M | 43,88M | 39,68M | 10,00M |
| Net Income | -644,76M | -463,66M | -328,07M | -239,48M | -186,48M |
| EPS (Diluted) | -1,44 | -1,69 | -1,58 | -1,36 | -1,05 |
| Gross Profit | -46,27M | 13,60M | 1,29M | -8,59M | 10,00M |
| Operating Income | -648,13M | -479,00M | -350,06M | -245,73M | -182,78M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,47B | 1,45B | 653,70M | 701,29M | 610,35M |
| Total Liabilities | 343,27M | 413,82M | 190,26M | 215,48M | 67,41M |
| Shareholders' Equity | 1,13B | 1,03B | 463,44M | 485,81M | 542,94M |
| Total Debt | 77,97M | 108,49M | 50,67M | 51,01M | 11,48M |
| Cash & Equivalents | 743,29M | 594,35M | 391,57M | 549,91M | 285,12M |
| Current Assets | 812,85M | 714,27M | 438,14M | 569,81M | 534,72M |
| Current Liabilities | 147,71M | 187,47M | 93,17M | 100,27M | 46,66M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#99 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026